SI1261622T1 - Preäśiĺ äśeni rekombinantni hlh s specifiäśno bioaktivnostjo in postopek za njegovo preäśiĺ äśenje - Google Patents
Preäśiĺ äśeni rekombinantni hlh s specifiäśno bioaktivnostjo in postopek za njegovo preäśiĺ äśenjeInfo
- Publication number
- SI1261622T1 SI1261622T1 SI200130709T SI200130709T SI1261622T1 SI 1261622 T1 SI1261622 T1 SI 1261622T1 SI 200130709 T SI200130709 T SI 200130709T SI 200130709 T SI200130709 T SI 200130709T SI 1261622 T1 SI1261622 T1 SI 1261622T1
- Authority
- SI
- Slovenia
- Prior art keywords
- purification
- specific bioactivity
- purified recombinant
- ion
- reverse phase
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000000746 purification Methods 0.000 title abstract 3
- 102000009151 Luteinizing Hormone Human genes 0.000 abstract 4
- 108010073521 Luteinizing Hormone Proteins 0.000 abstract 4
- 229940040129 luteinizing hormone Drugs 0.000 abstract 4
- 238000004255 ion exchange chromatography Methods 0.000 abstract 2
- 238000004007 reversed phase HPLC Methods 0.000 abstract 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 abstract 1
- 239000000356 contaminant Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Semiconductor Lasers (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00103692 | 2000-02-22 | ||
| PCT/EP2001/000666 WO2001062774A2 (en) | 2000-02-22 | 2001-01-22 | Purified lh |
| EP01907476A EP1261622B1 (en) | 2000-02-22 | 2001-01-22 | Purified recombinant hlh having a specific bioactivity and process for purification thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1261622T1 true SI1261622T1 (sl) | 2007-06-30 |
Family
ID=8167926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130709T SI1261622T1 (sl) | 2000-02-22 | 2001-01-22 | Preäśiĺ äśeni rekombinantni hlh s specifiäśno bioaktivnostjo in postopek za njegovo preäśiĺ äśenje |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7053054B2 (https=) |
| EP (2) | EP1777231A3 (https=) |
| JP (1) | JP4959898B2 (https=) |
| KR (1) | KR100808149B1 (https=) |
| CN (1) | CN100480258C (https=) |
| AT (1) | ATE356138T1 (https=) |
| AU (1) | AU780377B2 (https=) |
| BG (1) | BG65761B1 (https=) |
| BR (2) | BRPI0108553B8 (https=) |
| CA (1) | CA2399100C (https=) |
| CY (1) | CY1108056T1 (https=) |
| CZ (1) | CZ303274B6 (https=) |
| DE (1) | DE60127100T2 (https=) |
| DK (1) | DK1261622T3 (https=) |
| EA (1) | EA004385B1 (https=) |
| EE (1) | EE04932B1 (https=) |
| ES (1) | ES2278722T3 (https=) |
| HR (1) | HRP20020651B1 (https=) |
| HU (1) | HU227007B1 (https=) |
| IL (2) | IL151309A0 (https=) |
| MX (1) | MXPA02007867A (https=) |
| NO (1) | NO328693B1 (https=) |
| PL (1) | PL207728B1 (https=) |
| PT (1) | PT1261622E (https=) |
| RS (1) | RS50416B (https=) |
| SI (1) | SI1261622T1 (https=) |
| SK (1) | SK287041B6 (https=) |
| UA (2) | UA92145C2 (https=) |
| WO (1) | WO2001062774A2 (https=) |
| ZA (1) | ZA200206108B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE356138T1 (de) * | 2000-02-22 | 2007-03-15 | Applied Research Systems | Gereinigtes recombinantes hlh mit spezifischer bioaktivität und verfahren zu dessen reinigung |
| DE10235168A1 (de) * | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
| DE602004030546D1 (de) | 2003-03-04 | 2011-01-27 | Aspenbio Pharma Inc | LH zur Verwendung der Erhaltung einer oder mehreren Schwangerschaften durch Induktion der Bildung des sekundären Gelbkörpers. |
| CN1283792C (zh) * | 2003-11-14 | 2006-11-08 | 余伟明 | 生物大分子组分相分离法 |
| CA2544333A1 (en) * | 2003-12-22 | 2005-07-14 | Ares Trading S.A. | Method for purifying fsh |
| JP2007513192A (ja) * | 2004-10-04 | 2007-05-24 | ノベタイド，リミティド | ペプチド用の対イオン交換法 |
| AU2005303818B2 (en) * | 2004-11-09 | 2011-06-23 | Ares Trading S.A. | Method for purifying FSH |
| SG155183A1 (en) * | 2005-08-26 | 2009-09-30 | Ares Trading Sa | Process for the preparation of glycosylated interferon beta |
| EP1960419B1 (en) * | 2005-12-09 | 2016-03-16 | Ares Trading S.A. | Method for purifying fsh or a fsh mutant |
| CA2701221A1 (en) * | 2007-10-22 | 2009-04-30 | Merck Serono S.A. | Method for purifying an fc-containing protein |
| EP2203474A1 (en) * | 2007-10-22 | 2010-07-07 | Merck Serono S.A. | Method for purifying fc-fusion proteins |
| CN101928342B (zh) * | 2009-06-18 | 2013-05-08 | 上海天伟生物制药有限公司 | 一种高纯度绝经期促性腺素及其制备方法和用途 |
| CN106999546A (zh) * | 2014-05-01 | 2017-08-01 | 弗吉尼亚技术知识资产公司 | 角蛋白纳米材料及其制备方法 |
| CN104569441B (zh) * | 2015-01-19 | 2016-02-03 | 成都大熊猫繁育研究基地 | 大熊猫尿液促黄体素的酶联检测方法及其应用 |
| CA3140267A1 (en) | 2019-05-16 | 2020-11-19 | Ceva Sante Animale | Compositions and methods for increasing reproduction performance in non-human mammals using recombinant luteinizing hormone |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990002757A1 (en) * | 1988-09-02 | 1990-03-22 | Integrated Genetics, Inc. | Heteropolymeric protein |
| ES2098261T3 (es) * | 1989-02-21 | 1997-05-01 | Univ Washington | Formas modificadas de hormonas reproductoras. |
| US5087615A (en) * | 1989-03-17 | 1992-02-11 | Applied Research Systems Ars Holding N.V. | Novel method of ovulation induction in humans |
| IT1250075B (it) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
| IT1287138B1 (it) * | 1996-11-07 | 1998-08-04 | Ibsa Inst Biochimique Sa | Procedimento per la separazione e purificazione di fsh e lh |
| IL122732A0 (en) * | 1997-01-15 | 1998-08-16 | Akzo Nobel Nv | Liquid gonadotropin-containing formulation its preparation and a device containing same |
| SI0996629T1 (sl) * | 1997-06-25 | 2006-12-31 | Applied Research Systems | Analogi glikoproteinskega hormona povezanega z disulfidi, priprava in uporaba |
| ATE356138T1 (de) * | 2000-02-22 | 2007-03-15 | Applied Research Systems | Gereinigtes recombinantes hlh mit spezifischer bioaktivität und verfahren zu dessen reinigung |
-
2001
- 2001-01-22 AT AT01907476T patent/ATE356138T1/de active
- 2001-01-22 WO PCT/EP2001/000666 patent/WO2001062774A2/en not_active Ceased
- 2001-01-22 PL PL362891A patent/PL207728B1/pl unknown
- 2001-01-22 UA UAA200612399A patent/UA92145C2/uk unknown
- 2001-01-22 HR HR20020651A patent/HRP20020651B1/xx not_active IP Right Cessation
- 2001-01-22 JP JP2001562555A patent/JP4959898B2/ja not_active Expired - Lifetime
- 2001-01-22 SK SK1205-2002A patent/SK287041B6/sk not_active IP Right Cessation
- 2001-01-22 BR BRPI0108553A patent/BRPI0108553B8/pt not_active IP Right Cessation
- 2001-01-22 IL IL15130901A patent/IL151309A0/xx unknown
- 2001-01-22 DE DE60127100T patent/DE60127100T2/de not_active Expired - Lifetime
- 2001-01-22 EE EEP200200464A patent/EE04932B1/xx unknown
- 2001-01-22 CZ CZ20022856A patent/CZ303274B6/cs not_active IP Right Cessation
- 2001-01-22 DK DK01907476T patent/DK1261622T3/da active
- 2001-01-22 HU HU0301814A patent/HU227007B1/hu unknown
- 2001-01-22 US US10/204,554 patent/US7053054B2/en not_active Expired - Lifetime
- 2001-01-22 ES ES01907476T patent/ES2278722T3/es not_active Expired - Lifetime
- 2001-01-22 EA EA200200893A patent/EA004385B1/ru not_active IP Right Cessation
- 2001-01-22 RS YUP-603/02A patent/RS50416B/sr unknown
- 2001-01-22 CN CNB018053645A patent/CN100480258C/zh not_active Expired - Lifetime
- 2001-01-22 SI SI200130709T patent/SI1261622T1/sl unknown
- 2001-01-22 EP EP06016629A patent/EP1777231A3/en not_active Withdrawn
- 2001-01-22 PT PT01907476T patent/PT1261622E/pt unknown
- 2001-01-22 AU AU35436/01A patent/AU780377B2/en not_active Expired
- 2001-01-22 UA UA2002086889A patent/UA78676C2/xx unknown
- 2001-01-22 BR BR122012018280A patent/BR122012018280B8/pt not_active IP Right Cessation
- 2001-01-22 EP EP01907476A patent/EP1261622B1/en not_active Expired - Lifetime
- 2001-01-22 CA CA2399100A patent/CA2399100C/en not_active Expired - Fee Related
- 2001-01-22 KR KR1020027010624A patent/KR100808149B1/ko not_active Expired - Lifetime
- 2001-01-22 MX MXPA02007867A patent/MXPA02007867A/es active IP Right Grant
-
2002
- 2002-07-31 ZA ZA200206108A patent/ZA200206108B/en unknown
- 2002-08-14 BG BG107001A patent/BG65761B1/bg unknown
- 2002-08-18 IL IL151309A patent/IL151309A/en active IP Right Grant
- 2002-08-20 NO NO20023963A patent/NO328693B1/no not_active IP Right Cessation
-
2005
- 2005-11-28 US US11/287,341 patent/US20060079460A1/en not_active Abandoned
-
2007
- 2007-05-10 CY CY20071100638T patent/CY1108056T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1261622T1 (sl) | Preäśiĺ äśeni rekombinantni hlh s specifiäśno bioaktivnostjo in postopek za njegovo preäśiĺ äśenje | |
| HU1300063D0 (hu) | Tisztított hCG | |
| DK0906122T3 (da) | Aktiverede linkers og fremgangsmåde til at fremstille og oprense disse | |
| AU1316692A (en) | Process for low-temperature air fractionation | |
| MXPA01010522A (es) | Composiciones de gonadotropina altamente purificada y procedimiento para prepararlas. | |
| ES2161790T3 (es) | Procedimiento de separacion y de purificacion de proteinas dependientes de la vitamina k. | |
| KR900001854A (ko) | 환원형의 비글리코실화 재조합 인체 il₂, 그의 제조방법 및 의약품으로서의 용도 | |
| Hooper et al. | Histone III: II. ISOLATION AND SEQUENCES OF CHYMOTRYPTIC PEPTIDES FROM CALF THYMUS HISTONE III | |
| Hocart et al. | Improved antagonists of luteinizing hormone-releasing hormone modified in position 7 | |
| IT1245230B (it) | Procedimento di preparazione della timopentina |